BEIJING, Aug. 29, 2013 (GLOBE NEWSWIRE) -- Dehaier Medical Systems Ltd. (Nasdaq: DHRM ) ("Dehaier" or the "Company"), an emerging leader in the development, assembly, marketing and sales of medical devices and homecare medical products, today announced that it has established a powerful server in Beijing for its Morpheus Ox software, which currently enables hundreds of hospitals to upload sleep data after patients use the sleep holters and simultaneously generates sleep diagnosis reports for patients.
The Morpheus Ox System is a cost-effective, portable home sleep diagnostic and monitoring solution that enables the diagnosis of sleep disorders using a standard oximeter recording plethysmograph signal. By collecting and recording the physiological data from patients who wear the watch-sized device at home, the advanced automatic sleep scoring software makes an accurate and reliable sleep study diagnosis, including Apnea Hypopnea Index (AHI), sleep/wake time, and Cheyne-Stokes breathing patterns. The new generation Morpheus Ox is a comprehensive platform that manages a cost-effective sleep services operation, including patient electronic medical records, and sleep diagnostics results, as well as complete workflow management. The web-based automatic scoring and data management are able to increase operational efficiency and provide opportunities for us to offer other services by giving users valuable and timely clinical information to improve patient treatment.
Mr. Ping Chen, Chairman and Chief Executive Officer of Dehaier Medical, commented, "We invited a senior IT engineer from WideMed Ltd. to support our establishment of an efficient and safe server for Chinese users. The server is scalable and can, if expanded, support the needs of China's estimated 50 million sleep apnea patients. In addition, it provides convenient and safe service to quickly generate sleep reports for patients. We believe the system's strength and speed will drive popularization of the Morpheus Ox in China."
About Dehaier Medical Systems Ltd.
Dehaier is an emerging leader in the development, assembly, marketing and sale of medical products, including respiratory and oxygen homecare medical products. The company develops and assembles its own branded medical devices and homecare medical products from third-party components. The company also distributes products designed and manufactured by other companies, including medical devices from IMD (Italy), Welch Allyn (USA), HEYER (Germany), Timesco (UK), eVent Medical (US) and JMS (Japan). More information may be found at http://www.dehaier.com.cn
Forward-looking Statements
This news release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events, government approvals or performance, and underlying assumptions and other statements that are other than statements of historical facts, including in particular any implications regarding the Morpheus Ox server. These statements are subject to uncertainties and risks including, but not limited to, product and service demand and acceptance, changes in technology, economic conditions, the impact of competition and pricing, government regulation, future developments in payment for and demand for medical equipment and services, and other risks contained in reports filed by the company with the Securities and Exchange Commission. All such forward-looking statements, whether written or oral, and whether made by or on behalf of the company, are expressly qualified by the cautionary statements and any other cautionary statements which may accompany the forward-looking statements. In addition, the company disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date hereof.
Dehaier Medical Systems Limited Surie Liu +86 10-5166-0080 Dehaier Medical Systems Limited Tina He +86 10-5166-0080
